Company Registry

ZabBio Inc
Profile last edited on: 2/25/2021

Monoclonal antibody-based products addressing unmet needs in infectious diseases and reproductive health
Year Founded
2017
First SBIR Year
2018
Latest SBIR Award
2020
Program Status
Active

WikiProfile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

6160 Lusk Boulevard Suite C105
San Diego, CA 92121
   (443) 629-0104
   N/A
   N/A
Multiple Locations:   
Congressional District:   52
County:   San Diego

Public Profile

From the outset, management of ZabBio have defined the role of the firm as that of developing monoclonal antibody-based products to address unmet needs in infectious diseases and in reproductive health. Consistent with that latter area of focus, in late 2019, ZabBio was funded by the Bill andMelinda Gates Foundation to support the conduct of pre-clinical studies of a potential novel, non-hormonal female contraceptive. The firm produce mAb's for a variety of projects within N. Benthamiana plant expression system: mainly for human diseases, reproductive health, and conditions that are a threat to bio-defense and global health

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
5-9
Revenue Range
.5M-1M
VC funded?
No
Public/Private
Privately Held
Stock Info
---
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount Project Title
2021 2 NIH $1,883,226
Post-Exposure Immunotherapy for Ricin Exposure

Key People / Management

  Miles Burke Brennan --

  Henry Pham -- Research Associate

  Kevin Whaley --

SBIR firms in the news

There are no news available.